The global botanicals and acupuncture market size is expected to reach USD 241.2 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 21.2% from 2025 to 2030. The advent of nanotechnology in acupuncture-based treatments offers lucrative growth opportunities for the market. Nanotechnology has enabled the employment of nanosensors or nanochips to offer in vivo and real-time detection solutions in reactive molecules. Assessment of connections as well as dynamics, such as reactive molecules with respect to needle stimulation, is anticipated to offer novel insights for these treatments.
The consumer base for complementary medicine has increased due to the benefits and philosophies associated with it. Some philosophies include a high preference for natural products, the onset of illness is attributed to body imbalance, the ability of the body to heal itself, the treatment of the whole body, and the administration of easier therapies. Herbal medicine, naturopathy, and homeopathy are the three most adopted complementary therapies.
Increase in the penetration of internet and e-marketing channels, such as video counseling and other electronic methods, used for patient communication boosts the botanicals segment growth. Running Pay-Per-Click (PPP) advertisements and optimization of business with a rise in the adoption of mobile phones and tablet devices are among the two effective marketing strategies for the E-distribution of botanicals.
Request a free sample copy or view report summary: Botanicals And Acupuncture Market Report
By intervention, botanicals accounted for the largest revenue share of more than 68.5% in 2024 as they are extensively used in the form of herbal supplements, homeopathic medicines, and other natural products.
The traditional Chinese medicine therapies are finding applications in the recent treatment models associated with COVID-19 affected patients in China. This offers lucrative growth opportunities for the acupuncture market and operational entities in this market space.
Based on distribution method, direct sales dominated the global market in 2024 as the majority of the complementary therapeutic procedures, such as naturopathy and Ayurveda, demand direct sales/distribution post medical counseling of the patient.
The distance correspondence segment is anticipated to grow at a lucrative pace throughout the forecast period. This is due to the traction for long-distance energy treatments and virtual therapies, targeted towards increasing the salability potential of acupuncture therapies.
Europe accounted for the largest revenue share in 2024 owing to a significant increase in the number of herbal medicine registrations, of which 600 medicines were granted with marketing authorization.
Grand View Research has segmented the global botanicals and acupuncture market report based on intervention scope, distribution method, and region:
Botanicals And Acupuncture Intervention Scope Outlook (Revenue, USD Billion, 2018 - 2030)
Botanicals
Ayurveda
Naturopathy
Homeopathy
Acupuncture
Botanicals And Acupuncture Distribution Method Outlook (Revenue, USD Billion, 2018 - 2030)
Direct Sales
E-Sales
Distance Correspondence
Botanicals And Acupuncture Regional Outlook (Revenue, USD Billion, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Thailand
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
Rest of MEA
List of Key Players of Botanicals And Acupuncture Market
Modern Acupuncture
ARC Acupuncture & Physical Therapy
Ayush Ayurved
GC Biopharma Corporation
NatureKue, Inc.
Columbia Nutritional
Herb Pharm
Pure Encapsulations, LLC.
Sheng Chang Pharmaceutical Company
LKK Health Products Group Limited
Nordic Neutraceuticals
Helio USA, Inc.
"The quality of research they have done for us has been excellent..."